| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/27/2009 | US7482173 Method for attachment of silylated molecules to glass surfaces |
| 01/27/2009 | US7482172 Transmissible spongiform encephalopathies (TSE); Creutzfeldt-Jakob disease; immunoassay; kit |
| 01/27/2009 | US7482171 Angiotensin converting enzyme homolog and uses therefor |
| 01/27/2009 | US7482168 Using fluorescent organometallic polymers to detect explosive nitroaromatic compounds in air, water and solid surfaces |
| 01/27/2009 | US7482167 Microbead-based test methods for fluorescence imaging systems |
| 01/27/2009 | US7482166 Coupling device comprising interconnected syringes for mixing and/or dispensing viscous material; drug design |
| 01/27/2009 | US7482165 Method of preventing white blood cell interferences to red blood cell measurements of a blood sample |
| 01/27/2009 | US7482162 Separation vitamin d from protein; measurement; calibration; competitive binding; immunoassay |
| 01/27/2009 | US7482161 verifying the accuracy of measuring instruments that analyzes a sample of mammalian blood, by lysing leukocytes in the instrument and determinining the relative amounts of different types of blood cells in the sample |
| 01/27/2009 | US7482159 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 01/27/2009 | US7482147 polypeptides, proteins or fusion proteins having hydrolase enzyme activity, used for medical diagnosis and therapy |
| 01/27/2009 | US7482145 a conjugate of an alkaline phosphatase enzyme and an antibody or fragment which binds to target molecule in a detection assay |
| 01/27/2009 | US7482142 High-risk human papillomavirus detection |
| 01/27/2009 | US7482135 Using matrix metalloprotease concentration in urine to diagnose and prognose kidney disorders |
| 01/27/2009 | US7482134 Signals and molecular species involved in senescence |
| 01/27/2009 | US7482132 Detecting modulator of ornithine decarboxylase (ODC) activity; antitumor agents |
| 01/27/2009 | US7482131 quantitative or semi-quantitative analysis of the level of expression of protein kinase C (PKC), in samples obtained from the brain of the humans and comparing the expression with a control |
| 01/27/2009 | US7482130 Screening compounds which modulate ubiquitin ligase activity; cell proliferation; nuclear zinc finger protein (NP95); RNA interference; high throughput assay |
| 01/27/2009 | US7482129 MN/CA IX/CA9 and Renal Cancer Prognosis |
| 01/27/2009 | US7482128 Anti-feline albumin antibodies |
| 01/27/2009 | US7482126 Transcription factor as repressor of expression of E-cadherin; drug screening |
| 01/27/2009 | US7482124 Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema |
| 01/27/2009 | US7482121 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment |
| 01/27/2009 | US7482117 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 01/27/2009 | US7482115 Bacteriophage; antibiotics or bacteriostatic agents for treatment of antibiotic-resistant infections; medical equipment |
| 01/27/2009 | US7482012 Streptococcus pyogenes polypeptides and corresponding DNA fragments |
| 01/27/2009 | US7482008 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | US7481994 Calcium biosensor polypeptides and methods of use |
| 01/27/2009 | US7481977 For body fluid assays; comprises carousel mounted about a hub, which is disposed in a complementary shaped housing; chromatography |
| 01/27/2009 | US7481976 even if the lot of sensor chips is changed, parameters can be calibrated without changing memory keys; for quantitatively or qualitatively analyzing components of a body fluid, such as glucose, hemoglobin, etc |
| 01/27/2009 | US7481975 Hydrogen peroxide indicator and method |
| 01/27/2009 | US7481776 Method and apparatus for penetrating tissue |
| 01/27/2009 | CA2438168C Modulated release particles for aerosol delivery |
| 01/27/2009 | CA2388646C Methods and compositions utilizing quinazolinones |
| 01/27/2009 | CA2380783C Human monoclonal antibodies to prostate specific membrane antigen |
| 01/27/2009 | CA2377508C Pcr primer constructs for use in an integrated signalling system |
| 01/27/2009 | CA2361545C Purification of biological substances |
| 01/27/2009 | CA2360762C Sebocytes, sebocyte cell lines and applications thereof |
| 01/27/2009 | CA2355199C Method for monitoring advanced separation and/or ion exchange processes |
| 01/27/2009 | CA2342042C Biosensor electromagnetic noise cancellation |
| 01/27/2009 | CA2339821C Enzymatic measurement of mycophenolic acid |
| 01/27/2009 | CA2337894C Co2 sensor |
| 01/27/2009 | CA2319206C Peptide structures and their use in diagnosis of herpes simplex virus type 2 |
| 01/27/2009 | CA2295141C Use of a fluorescent protein for detecting interaction between a target protein and its ligand |
| 01/27/2009 | CA2293677C Method for assay of antibodies and antibody assay device |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2236837C Detection of mammary tumor virus-like sequences in human breast cancer |
| 01/27/2009 | CA2213709C Novel methods for diagnosing benign prostatic diseases |
| 01/27/2009 | CA2213694C Composite waveguide for solid phase binding assays |
| 01/27/2009 | CA2197321C Optical waveguide method for detecting specific binding events by light scattering |
| 01/27/2009 | CA2135644C Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/26/2009 | CA2638267A1 System and method for measurement of degree of moisture stratification in a paper or board |
| 01/25/2009 | CA2638241A1 Open circuit delay devices, systems, and methods for analyte measurement |
| 01/24/2009 | CA2638239A1 Test strip and connector |
| 01/22/2009 | WO2009012488A1 Assay for human anti-egrf variant iii antibodies |
| 01/22/2009 | WO2009012435A1 Conformational entropy in molecular recognition |
| 01/22/2009 | WO2009012384A2 Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1 |
| 01/22/2009 | WO2009012372A1 Methods and apparatuses for detecting analytes in biological fluid of an animal |
| 01/22/2009 | WO2009012359A2 Matrix metalloprotease targeting nucleic acids |
| 01/22/2009 | WO2009012356A2 Imaging nucleic acid binding proteins |
| 01/22/2009 | WO2009012309A2 Nucleic acid based fluorescent sensor for divalent copper ion detection |
| 01/22/2009 | WO2009012237A1 Compositions and methods for identifying substrate specificity of inhibitors of gamma secretase |
| 01/22/2009 | WO2009012220A2 Analyte detection assays |
| 01/22/2009 | WO2009012185A1 Polynucleotide capture materials, and methods of using same |
| 01/22/2009 | WO2009012175A1 Antibodies specific for the c-terminal regulatory domain of egfr and their use |
| 01/22/2009 | WO2009012156A2 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 01/22/2009 | WO2009012140A2 Drug selection for lung cancer therapy using antibody-based arrays |
| 01/22/2009 | WO2009012110A2 Unique calibrator polynucleotides and methods of using in quantitative nucleic acid assays |
| 01/22/2009 | WO2009012095A1 Inspection apparatus and method using penetrating radiation |
| 01/22/2009 | WO2009012094A1 Osmometric heart monitoring device and methods |
| 01/22/2009 | WO2009011885A1 Modulators of hematopoiesis |
| 01/22/2009 | WO2009011829A1 System and method for measuring starch gelatinisation in a feed production system |
| 01/22/2009 | WO2009011808A1 Droplet-based selection |
| 01/22/2009 | WO2009011778A1 βMETHOD FOR IDENTIFYING MODULATORS OF LRRTM1, LRRTM2 AND LRRTM4 USEFUL FOR TREATING ALZHEIMER'S DISEASE |
| 01/22/2009 | WO2009011770A2 Compositions and methods for diagnosing and assesing inflammatory myopathies |
| 01/22/2009 | WO2009011674A1 Trans-1,2-diphenylethylene derivatives and nanosensors made therefrom |
| 01/22/2009 | WO2009011664A1 Solution for determining ovulatory period in women from a test tube of urine |
| 01/22/2009 | WO2009011593A1 Detector system and method to detect or determine a specific gas within a gas mixture |
| 01/22/2009 | WO2009011500A2 Methods for decreasing false signals in immunoassay to detect a multimeric form from a monomeric form of multimer-forming polypeptides |
| 01/22/2009 | WO2009011499A1 Quantitative analysis method of pelargonium sidoides syrup or solution |
| 01/22/2009 | WO2009011466A1 CANCER EVALUATION METHOD USING HAPTOGLOBIN β-CHAIN DEFINED BY ANTIBODY RM2 |
| 01/22/2009 | WO2009011426A1 Screening method utilizing c-met which is novel substrate for γ-secretase |
| 01/22/2009 | WO2009011195A1 Semiconductor nanoparticle phosphor, method for production of the same, and semiconductor nanoparticle label utilizing the same |
| 01/22/2009 | WO2009011188A1 Near infrared light-emitting phosphor nanoparticle, method for producing the same, and agent for labeling biological substance using the same |
| 01/22/2009 | WO2009010976A2 Compositions and methods for purifying and crystallizing molecules of interest |
| 01/22/2009 | WO2009010885A2 Use of cd200 as a mesenchymal stem cells marker |
| 01/22/2009 | WO2009010790A1 Methods of screening for anti-angiogenic compounds |
| 01/22/2009 | WO2009010766A1 Method |
| 01/22/2009 | WO2009010764A1 Quantification of analytes using accelerator mass spectrometry |
| 01/22/2009 | WO2009010687A2 Target enzyme in the treatment of acne |
| 01/22/2009 | WO2009010678A2 Method of determining the fuel content in a combustion engine lubricating oil |
| 01/22/2009 | WO2009010656A2 Device for controlling the immersion of probes and/or sensors measuring the physico-chemical parameters of liquids, and associated measuring system |
| 01/22/2009 | WO2009010614A1 Use of a new isolate of neospora caninum for the development of diagnostic tests and for preparation of products for treatment and prevention of the infection caused by neospora |
| 01/22/2009 | WO2009010611A1 Polypeptides derived from psap protein (presenilin 1 - associated protein) capable of causing apoptosis and uses of the same |
| 01/22/2009 | WO2009010489A1 Method for determining the concentration of a molecule |
| 01/22/2009 | WO2009010343A1 Method and system for the online detection of at least one expansion property of a running paper or cardboard web |
| 01/22/2009 | WO2009010296A2 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
| 01/22/2009 | WO2009010240A1 Analysis of doping compounds |